CRISPR base editing applications for identifying cancer-driving mutations

9Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

CRISPR base editing technology is a promising genome editing tool as (i) it does not require a DNA template to introduce mutations and (ii) it avoids creating DNA double-strand breaks, which can lead to unintended chromosomal alterations or elicit an unwanted DNA damage response. Given many cancers originate from point mutations in cancer-driving genes, the application of base editing for either modelling tumour development, therapeutic editing, or functional screening is of great promise. In this review, we summarise current DNA base editing technologies and will discuss recent advancements and existing hurdles for its usage in cancer research.

Cite

CITATION STYLE

APA

Pal, M., & Herold, M. J. (2021, February 1). CRISPR base editing applications for identifying cancer-driving mutations. Biochemical Society Transactions. Portland Press Ltd. https://doi.org/10.1042/BST20200550

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free